SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement.
性状
Solid
IC50 & Target[1][2]
SENP1
体外研究(In Vitro)
SENP1-IN-1 may improve the sensitivity of tumor cells to irradiation.SENP1-IN-1 (0.7-20 μM; 72 hours)has cytotoxic for Hella cells with an IC50 of >20μM. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Cytotoxicity Assay
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Li, Yiliang, et al. Preparation of ursolic acid derivatives useful as SENP1 inhibitors and tumor radiosensitizer. CN110627860A.
溶解度数据
In Vitro: DMSO : 100 mg/mL (175.18 mM; Need ultrasonic)配制储备液